SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-076704
Filing Date
2011-08-12
Accepted
2011-08-12 14:18:01
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b82615e10vq.htm 10-Q 353329
2 EX-31.1 b82615exv31w1.htm EX-31.1 5712
3 EX-31.2 b82615exv31w2.htm EX-31.2 5992
4 EX-32.1 b82615exv32w1.htm EX-32.1 3814
  Complete submission text file 0000950123-11-076704.txt   1524937

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT oxgn-20110630.xml EX-101.INS 185879
6 EX-101 SCHEMA DOCUMENT oxgn-20110630.xsd EX-101.SCH 9615
7 EX-101 CALCULATION LINKBASE DOCUMENT oxgn-20110630_cal.xml EX-101.CAL 23231
8 EX-101 LABELS LINKBASE DOCUMENT oxgn-20110630_lab.xml EX-101.LAB 93445
9 EX-101 PRESENTATION LINKBASE DOCUMENT oxgn-20110630_pre.xml EX-101.PRE 59905
10 EX-101 DEFINITION LINKBASE DOCUMENT oxgn-20110630_def.xml EX-101.DEF 10920
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 111030688
SIC: 2836 Biological Products, (No Diagnostic Substances)